Loading...
Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions
Marinello, A. Vasseur, D. Conci, N. Lindsay, Colin R Metro, G. Ferrara, R. Eisert, A. Citarella, F. Fallet, V. Audigier-Valette, C.
Marinello, A.
Vasseur, D.
Conci, N.
Lindsay, Colin R
Metro, G.
Ferrara, R.
Eisert, A.
Citarella, F.
Fallet, V.
Audigier-Valette, C.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
Marinello A, Vasseur D, Conci N, Lindsay C, Metro G, Ferrara R, et al. Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions. European Journal of Cancer. 2022 Oct;174:S26-S. PubMed PMID: WOS:000876973400062.